ATROPINE SULFATE Drug Patent Profile
✉ Email this page to a colleague
When do Atropine Sulfate patents expire, and when can generic versions of Atropine Sulfate launch?
Atropine Sulfate is a drug marketed by Us Army, Amneal, Apotex, Bausch And Lomb Inc, Mankind Pharma, Rising, Accord Hlthcare, Am Regent, Hospira, Intl Medication Sys, Medefil Inc, Fresenius Kabi Usa, and Hikma. and is included in sixteen NDAs.
The generic ingredient in ATROPINE SULFATE is atropine sulfate. There are twenty-three drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the atropine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Atropine Sulfate
A generic version of ATROPINE SULFATE was approved as atropine sulfate by HOSPIRA on July 9th, 2001.
Summary for ATROPINE SULFATE
US Patents: | 0 |
Applicants: | 13 |
NDAs: | 16 |
Finished Product Suppliers / Packagers: | 20 |
Raw Ingredient (Bulk) Api Vendors: | 138 |
Clinical Trials: | 50 |
Patent Applications: | 4,145 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in ATROPINE SULFATE? | ATROPINE SULFATE excipients list |
DailyMed Link: | ATROPINE SULFATE at DailyMed |
Recent Clinical Trials for ATROPINE SULFATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Limited | Phase 1 |
Shandong University of Traditional Chinese Medicine | N/A |
Shanghai Eye Disease Prevention and Treatment Center | N/A |
Pharmacology for ATROPINE SULFATE
Drug Class | Anticholinergic Cholinergic Muscarinic Antagonist |
Mechanism of Action | Cholinergic Antagonists Cholinergic Muscarinic Antagonists |
Anatomical Therapeutic Chemical (ATC) Classes for ATROPINE SULFATE
US Patents and Regulatory Information for ATROPINE SULFATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Us Army | ATROPINE SULFATE | atropine sulfate | AEROSOL, METERED;INHALATION | 020056-001 | Sep 19, 1990 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hospira | ATROPINE SULFATE | atropine sulfate | SOLUTION;INTRAVENOUS | 021146-003 | Jul 9, 2001 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Accord Hlthcare | ATROPINE SULFATE | atropine sulfate | SOLUTION;INTRAVENOUS | 212868-001 | Jul 26, 2021 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Bausch And Lomb Inc | ATROPINE SULFATE | atropine sulfate | SOLUTION/DROPS;OPHTHALMIC | 213581-001 | Mar 15, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Am Regent | ATROPINE SULFATE | atropine sulfate | SOLUTION;INTRAVENOUS | 216120-001 | May 26, 2022 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |